Business
Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting
QUEENSBURY, N.Y., April 01, 2026--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will attend the Society of Interventional Radiology (SIR) 2026 Annual Scientific Meeting, taking place April 11–15, 2026, in Toronto, Canada.
About this update from Delcath Systems, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/ab4e6a159ae02f7cfdc3c252a8660a27"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gUYuI4B8p3R1z5Ds_fZoHg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/ab4e6a159ae02f7cfdc3c252a8660a27","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/JAAPX7oroelNu8H4xTQDdg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0/https://media.zenfs.com/en/business-wire.com/ab4e6a159ae02f7cfdc3c252a8660a27","width":1024,"height":512}},"lazy":false},{"type":"text","content":"QUEENSBURY, N.Y., April 01, 2026--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will attend the Society of Interventional Radiology (SIR) 2026 Annual Scientific Meeting, taking place April 11–15, 2026, in Toronto, Canada.","length":338,"tagName":"p"},{"type":"text","content":"At the event, Delcath’s Hepatic Delivery System for use in percutaneous hepatic perfusion will be featured in three presentations.","length":130,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"On April 13, 2026, at 2:40 PM ET, Dr. Eric Wehrenberg-Klee, an interventional radiologist at Massachusetts General Hospital and Assistant Professor of Radiology at Harvard Medical School, will discuss his HEPZATO user experience at the SIR Innovation Hub;","length":255,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":255,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"On April 15, 2026, at 12:18 PM ET, Dr. David Eschelman, Professor of Radiology at Thomas Jefferson University, will present his initial commercial experience with percutaneous hepatic perfusion (PHP) for the treatment of liver metastases from uveal melanoma at Booth 701B; and","length":276,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":276,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"On April 15, 2026, at 12:27 PM ET, Dr. Mustafa Ege Seker, Research Fellow in the Department of Radiology, Section of Interventional Radiology from the University of Wi...